Page last updated: 2024-10-26

dipyridamole and AIDS Seroconversion

dipyridamole has been researched along with AIDS Seroconversion in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

Excerpt	Relevance	Reference
"Dipyridamole was then begun at 600 mg/day (subjects 1 to 3) or 450 mg/day (subjects 4 to 11), and zidovudine and dipyridamole pharmacokinetics were measured on day 5."	1.29	Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects. ( Flexner, C; Hendrix, CW; Kuwahara, S; Lietman, PS; Pennypacker, S; Szebeni, J; Weinstein, JN, 1994)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hendrix, CW	1
Flexner, C	1
Szebeni, J	1
Kuwahara, S	1
Pennypacker, S	1
Weinstein, JN	1
Lietman, PS	1
Foga, IO	1
Nath, A	1
Hasinoff, BB	1
Geiger, JD	1

Other Studies

2 other studies available for dipyridamole and AIDS Seroconversion

Article	Year
Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:5 Topics: Adult; Dipyridamole; Drug Combinations; Drug Interactions; HIV Seropositivity; Humans; Iodine Radioi	1994
Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Dec-01, Volume: 16, Issue:4 Topics: Anti-HIV Agents; Antioxidants; Dipyridamole; Dose-Response Relationship, Drug; HIV Antibodies; HIV E	1997

Article

Year

Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects.

Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:5

Topics: Adult; Dipyridamole; Drug Combinations; Drug Interactions; HIV Seropositivity; Humans; Iodine Radioi

1994

Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Dec-01, Volume: 16, Issue:4

Topics: Anti-HIV Agents; Antioxidants; Dipyridamole; Dose-Response Relationship, Drug; HIV Antibodies; HIV E

1997